Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Mar 27.
Published in final edited form as: Lancet. 1994 Feb 12;343(8894):391–392. doi: 10.1016/s0140-6736(94)91226-2

New arenavirus isolated in Brazil

Terezinha Lisieux M Coimbra 1, Elza S Nassar 1, Marcelo N Burattini 1, Luiza Terezinha Madia de Souza 1, Ivani B Ferreira 1, Iray M Rocco 1, Amelia P A Travassos da Rosa 1, Pedro F C Vasconcelos 1, Francisco P Pinheiro 1, James W LeDuc 1, Rebeca Rico-Hesse 1, Jean-Paul Gonzalez 1, Peter B Jahrling 1, Robert B Tesh 1,
PMCID: PMC3313646  NIHMSID: NIHMS363935  PMID: 7905555

Abstract

A new arenavirus, called Sabiá, was isolated in Brazil from a fatal case of haemorrhagic fever initially thought to be yellow fever. Antigenic and molecular characterisation indicated that Sabiá virus is a new member of the Tacaribe complex. A laboratory technician working with the agent was also infected and developed a prolonged, non-fatal influenza-like illness. Sabiá virus is yet another arenavirus causing human disease in South America.


Four arenaviruses (Lassa, Junin, Machupo, and Guanarito) have been associated with haemorrhagic disease in man. 1,2 Although each has a distinct geographic distribution, they have common modes of transmission and the diseases associated with them (Lassa, Argentinian, Bolivian, and Venezuelan haemorrhagic fevers, respectively) have similar clinical manifestations and high death rates. 1,3 We report isolation of a new arenavirus from a fatal case of haemorrhagic fever in São Paulo, Brazil.

The index case was a 25-year-old female agricultural engineer who was admitted on Jan 12,1990, after 12 days of fever, headache, myalgia, nausea, vomiting, and weakness. The patient’s history was unremarkable. She worked mainly in an office. She had not travelled out of São Paulo State for 2 months before her illness. The 10 days preceding onset were spent in two different cities with family and friends, all of whom were well.

Examination revealed an acutely ill, somnolent, and mildly dehydrated woman with a very red oropharynx. Laboratory studies (table) indicated leucopenia and slightly elevated aspartate aminotransferase. The differential diagnoses included sepsis, leptospirosis, malaria, hepatitis, and yellow fever. Treatment included intravenous fluids, electrolytes, and cefoxitin (1 g every 6 h) and amikacin (500 mg every 12 h). Over the next 3 days, the patient worsened with haematemesis, vaginal bleeding, and conjunctival petechiae. She developed increasing somnolence, tremors, difficulty in walking, and generalised tonic-clonic convulsions. On the third day, the patient went into coma and unresponsive shock; laboratory tests were abnormal (table). Death occurred on the fourth day. Principal necropsy findings were: diffuse pulmonary oedema and congestion with intraparenchymal haemorrhages; hepatic congestion with focal haemorrhage and necrosis; renal oedema and acute tubular necrosis; splenic enlargement and congestion; and massive gastrointestinal haemorrhage.

Table.

Laboratory findings


Admission
Day 3
Day 4
Haemoglobin (g/dL) 12·4 11·0 8·3–4·9
Total leucocytes (× 109/L) 3·7 5·9 7·7
Neutrophils (%) 86 78 54
Lymphocytes (%) 13 19 38
Platelets (× 109/L) >150 90 36
Prothombin time(s) .. 14·7 17
Fibrinogen (mg/dL) .. 155 115
Creatinine (mg/dL) 0·9 2·2 3·1
Aspartate aminotransferase (U/L) 96 3230 3180
Alanine aminotransferase (U/L) 35 770 820
Alkaline phosphatase (U/L) .. .. 491
Total bilirubin (mg/dL) 0·7 4·1 2·0
Direct bilirubin (mg/dL) 0·3 3·8 1·4

A blood sample taken shortly before death was submitted to the Adolfo Lutz Institute, where it was inoculated intracerebrally into newborn mice. A filterable agent was isolated from brains of the sick and dying mice. Because this agent did not react with immune sera prepared to human pathogenic viruses commonly encountered in Brazil (including yellow fever), it was forwarded to the Evandro Chagas Institute and then to the Yale Arbovirus Research Unit and the US Army Medical Research Institute of Infectious Diseases for further study. Results of complement-fixation, immunofluorescence, and neutralisation indicated that the agent, called Sabiá virus after the name of the community where the patient was staying when she became ill, is a new member of the Tacaribe complex of the genus Arenavirus.4 250 nucleotides from the 3′ end of the S segment of Sabiá virus RNA were compared with those of five other Tacaribe complex viruses (Junin, Machupo, Guanarito, Tacaribe, and Pichinde) by limited sequence analysis.5,6 Sabiá virus was 56% divergent from Junin, Machupo, and Guanarito viruses. The source of infection in the index case is unknown, but it seems likely that Sabiá virus exists in a rodent reservoir.

During characterisation of the virus in Belem, a 39-year-old laboratory technician was infected, probably by aerosol.7 He had a severe illness (temperature 38–40°C, chills, malaise, headache, generalised myalgia, sore throat, conjunctivitis, nausea, vomiting, diarrhoea, epigastric pain, and bleeding gums) for 15 days. Besides leucopenia (2·5 × 109/L), laboratory values remained normal. Admission and intravenous fluids were required and the patient recovered. Seroconversion to Sabiá virus was demonstrated in paired acute and convalescent sera.

The signs and symptoms in our two patients were similar to those of the other arenavirus haemorrhagic fevers.1,2,8 Liver damage is often observed in patients dying of such fevers.8,9 The histopathological appearance of the liver at necropsy is indistinguishable from that of yellow fever.

Our two cases illustrate the difficulty in diagnosing arenavirus infections. These illnesses are insidious and initially indistinguishable from various other common non-specific viral infections.1,8. If they become haemorrhagic, they can be misdiagnosed as yellow fever or dengue haemorrhagic fever.1,2,8 Virological confirmation is essential to establish a correct diagnosis.

Acknowledgments

This work was supported in part by grants AI-10984, AI-33983, and AI-01124 from the National Institutes of Health. J-P G was supported by the Institut Francais de Recherche Scientifique Pour Le Developpement en Cooperation (ORSTOM).

References

  • 1.Johnson KM. Arenaviruses. In: Evans AS, editor. Viral infections of humans. 3. New York: Plenum Press; 1989. pp. 133–52. [Google Scholar]
  • 2.Salas R, de Manzione N, Tesh RB, et al. Venezuelan haemorrhagic fever. Lancet. 1991;338:1033–36. doi: 10.1016/0140-6736(91)91899-6. [DOI] [PubMed] [Google Scholar]
  • 3.Childs JE, Peters CJ. Ecology and epidemiology of arenaviruses and their hosts. In: Salvato MS, editor. The Arenaviridae. New York: Plenum Press; 1993. pp. 331–84. [Google Scholar]
  • 4.Buchmeier MJ. Family Arenaviridae. In: Francki RIB, Fauquet CM, Knudson DL, Brown F, editors. Classification and nomenclature of viruses. Wien: Springer-Verlag; 1991. pp. 284–89. [Google Scholar]
  • 5.Clegg JCS. Molecular phytogeny of the arenaviruses and guide to published sequence data. In: Salvato MS, editor. The Arenaviridae. New York: Plenum Press; 1993. pp. 175–87. [Google Scholar]
  • 6.Rico-Hesse R, Pallansch M, Nottay B, Kew OM. Geographic distribution of wild poliovirus type 1 genotypes. Virology. 1987;160:311–22. doi: 10.1016/0042-6822(87)90001-8. [DOI] [PubMed] [Google Scholar]
  • 7.Vasconcelos PFC, Travassos da Rosa APA, Rodrigues SG, et al. Infeccao humana pelo virus SP H 114202 (Arenavirus: familia Arenaviridae): aspectos clinicos e laboratoriais de uma nova doenca. Rev Inst Med Trop São Paulo. doi: 10.1590/s0036-46651993000600008. (in press) [DOI] [PubMed] [Google Scholar]
  • 8.Fisher-Hock SP. Arenavirus pathophysiology. In: Salvato MS, editor. The Arenaviridae. New York: Plenum Press; 1993. pp. 299–323. [Google Scholar]
  • 9.Walker DH, Murphy FA. Pathology and pathogenesis of arenaviral infections. Curr Topics Microbiol Immunol. 1987;133:89–113. doi: 10.1007/978-3-642-71683-6_7. [DOI] [PubMed] [Google Scholar]

RESOURCES